Etanercept (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Etanercept" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

2doi.org

2^nd place

5^th place

2nih.gov

4^th place

8^th place

2web.archive.org

1^st place

2^nd place

1drugs.com

399^th place

169^th place

1cbz.si

low place

607^th place

1termania.net

low place

34^th place

1semanticscholar.org

11^th place

51^st place

1archive.org

6^th place

9^th place

1handle.net

102^nd place

416^th place

1cnn.com

28^th place

86^th place

1fda.gov

447^th place

409^th place

1enbrel.com

low place

archive.org

Braun J, McHugh N, Singh A, Wajdula JS, Sato R (Junij 2007). »Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly«. Rheumatology. 46 (6): 999–1004. doi:10.1093/rheumatology/kem069. PMID 17389658.

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BJENALISTI%5D=1)+(%5BSEZNAMUCINKNAZIV%5D=_etanercept*)&SearchOrder=4&SearchMax=301 Centralna baza zdravil, vpogled: 18. 9. 2020

cnn.com

money.cnn.com

»Wyeth and Amgen heighten warning of life-threatening infections on skin drug Enbrel«. Arhivirano iz prvotnega spletišča dne 5. maja 2008. Pridobljeno 2. maja 2008.

doi.org

Feldmann M, Maini RN (Oktober 2003). »TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases«. Nature Medicine. 9 (10): 1245–50. doi:10.1038/nm939. PMID 14520364. S2CID 52860838.
Braun J, McHugh N, Singh A, Wajdula JS, Sato R (Junij 2007). »Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly«. Rheumatology. 46 (6): 999–1004. doi:10.1093/rheumatology/kem069. PMID 17389658.

drugs.com

»Etanercept Use During Pregnancy«. Drugs.com. 24. januar 2020. Pridobljeno 13. avgusta 2020.

enbrel.com

»Prescribing Information – Enbrel«. Arhivirano iz prvotnega spletišča dne 14. oktobra 2007. Pridobljeno 10. januarja 2008.

fda.gov

Safety Update on TNF- α Antagonists: Infliximab and Etanercept (PDF). Food and Drug Administration. str. 13–14. Pridobljeno 20. decembra 2013.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

nih.gov

pubmed.ncbi.nlm.nih.gov

Feldmann M, Maini RN (Oktober 2003). »TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases«. Nature Medicine. 9 (10): 1245–50. doi:10.1038/nm939. PMID 14520364. S2CID 52860838.
Braun J, McHugh N, Singh A, Wajdula JS, Sato R (Junij 2007). »Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly«. Rheumatology. 46 (6): 999–1004. doi:10.1093/rheumatology/kem069. PMID 17389658.

semanticscholar.org

api.semanticscholar.org

Feldmann M, Maini RN (Oktober 2003). »TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases«. Nature Medicine. 9 (10): 1245–50. doi:10.1038/nm939. PMID 14520364. S2CID 52860838.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5514530/etanercept?query=etanercept&SearchIn=All Slovenski medicinski e-slovar, vpogled: 18. 9. 2020.

web.archive.org

»Wyeth and Amgen heighten warning of life-threatening infections on skin drug Enbrel«. Arhivirano iz prvotnega spletišča dne 5. maja 2008. Pridobljeno 2. maja 2008.
»Prescribing Information – Enbrel«. Arhivirano iz prvotnega spletišča dne 14. oktobra 2007. Pridobljeno 10. januarja 2008.